
Krishna Institute of Medical Sciences Ltd
Krishna Inst.Medi
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹275.46 Cr.
| EX-Date | Purpose |
|---|---|
| 10 08 2021 | Quarterly Results |
| 10 11 2021 | Quarterly Results |
| 10 02 2022 | Quarterly Results |
| 19 05 2022 | Audited Results & Dividend |
| 10 08 2022 | Quarterly Results |
| 11 11 2022 | Quarterly Results |
| 04 01 2023 | Inter alia, to consider and approve A meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, January 4, 2023, inter alia, to consider and approve raising of funds by way of issuance of Non-Convertible Debentures (NCDs), aggregating to Rs. 300 Crores in one or more tranches over a period of time |
| 09 02 2023 | Quarterly Results |
| 18 05 2023 | Audited Results & Quarterly Results |
| 07 08 2023 | Quarterly Results |
| 07 11 2023 | Quarterly Results |
| 03 02 2024 | Quarterly Results |
| 09 11 2024 | Quarterly Results |
| 06 02 2025 | Quarterly Results |
| 12 05 2025 | Audited Results |
| 07 11 2025 | Quarterly Results |
| 06 02 2026 | Quarterly Results |
| 11 03 2026 | Rights Issue & Right Issue of Equity Shares & Inter alia, to consider and approve and evaluate the proposal for raising of funds by way of issuance of equity shares, in one or more tranches by way of one or more Qualified Institutions Placements ( QIP ) and/or rights issue in accordance with the applicable provisions of the Companies Act, 2013 and the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, (each as amended), or through any other permissible mode or any combination thereof, in such manner, and on such terms and conditions as may be deemed appropriate by the Board in its absolute discretion, subject to the receipt of necessary approvals, including the approval of the members of the Company and such other regulatory and statutory approvals as may be required, if any, as may be required and determination of the issue price. |
